Electrophysiological mechanisms for ventricular arrhythmias in patients with myocardial ischemia: Anesthesiologic considerations, pt II

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 11, Issue 5, 1997, Pages 641-656

  Gallagher, John D ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Arrhythmias; Coronary artery disease; Electrophysiology; Myocardial ischemia

Indexed keywords

AMIODARONE; ANESTHETIC AGENT; APRINDINE; DISOPYRAMIDE; ENFLURANE; FENTANYL; HALOTHANE; ISOFLURANE; LIDOCAINE; METOPROLOL; MEXILETINE; PINDOLOL; PROCAINAMIDE; PROPRANOLOL; QUINIDINE; TOCAINAMIDE; VERAPAMIL;

ANESTHESIA; DISEASE COURSE; DRUG EFFECT; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0030750447     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(97)90021-5     Document Type: Review

References (139)

1. Porter WT: On the results of ligation of the coronary arteries. J Physiol 15:121-138, 1894
2. Harris AS: Delayed development of ventricular ectopic rhythms following experimental coronary occlusion. Circulation 1:1318-1328, 1950
3. Harris AS, Bisteni A, Russell RA, et al: Excitatory factors in ventricular tachycardia resulting from myocardial ischemia. Science 119:200-203, 1954
4. Hoffman BF, Cranefield PF: Electrophysiology of the Heart. Mount Kisco, NY, Futura, 1976
5. Buchanan JW, Saito T, Gettes LS: The effects of antiarrhythmic drugs, stimulation frequency, and potassium induced resting potential changes on conduction velocity and dV/dt in guinea pig myocardium. Circ Res 56:696-703, 1985
6. Cranefield PF: The Conduction of the Cardiac Impulse. Mount Kisco, NY, Futura, 1975, p 404
7. Opie LH, Clusin WT: Cellular mechanism for ischemic ventricular arrhythmias. Annu Rev Med 41:231-238, 1990
8. McPherson GA: Current trends in the study of potassium channel openers. Gen Pharmacol 24:275-281, 1993
9. + channel activators in cardiac electrophysiology and arrhythmias. Circulation 85:1627-1629, 1992
10. Thornton JD, Thornton CS, Sterling DL, Downey JM: Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ Res 72:44-49, 1993
11. Grover GJ, McCullough JR, Henry DE, et al: Anti-ischemic effects of the potassium activators pinacidil and cromokalim and the reversal of these with the potassium channel blocker glyburide. J Pharmac Exp Ther 251:98-104, 1989
12. Carlsson L, Abrahamsson C, Drews C, Duker G: Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization. Circulation 85:1491-1500, 1992
13. + current activated by pinacidil. Circ Res 68:1127-1137, 1991
14. Bril A, Man RY: The role of potassium and sodium-calcium exchange currents in the action potential durations of normal Purkinje fibers and Purkinje fibers surviving infarction. Cardiovasc Res 23:410-416, 1989
15. Imanishi S, Arita M, Aomine M, Kiyosue T: Antiarrhythmic effects of nicorandil on canine Purkinje fibers. J Cardiovasc Pharmacol 6:772-779, 1984
16. Kerr MJ, Wilson R, Shanks RG: Suppression of ventricular arrhythmias after coronary artery ligation by pinacidil, a vasodilator drug. J Cardiovasc Pharmacol 7:875-883, 1985
17. + activity in swine. Circulation 61:768-778, 1980
18. Lee H-C, Mohabir R, Smith N, et al: Effect of ischemia on calcium-dependent fluorescence transients in rabbit hearts containing Indo 1: Correlation and monophasic action potentials and contraction. Circulation 78:1047-1059, 1988
19. Opie LH, Coetzee WA: Effects of components of ischemia and metabolic inhibition on delayed afterdepolarizations in guinea-pig papillary muscle. Circ Res 61:157-167, 1987
20. 1-adrenergic stimulation: A potential role for receptor mediated activation of sarcolemmal sodium-hydrogen exchange. Cardiovasc Res 29:222-230, 1995
21. + exchange inhibitors in cardiac ischemia. J Mol Cell Cardiol 24:731-740, 1992
22. + exchange and reperfusion arrhythmias: Protection by intracoronary infusion of a novel inhibitor. Am J Physiol 267:H2430-H2440, 1994
23. 23Na-nuclear magnetic resonance study of the isolated rat heart. Circulation 86:302-310, 1992
24. Downar E, Janse MJ, Durrer D: The effects of acute coronary artery occlusion on subepicardial transmembrane potentials in the intact porcine heart. Circulation 56:217-224, 1977
25. Janse MJ, Kleber AG: Electrophysiological changes and ventricular arrhythmias in the early phase of regional myocardial ischemia. Circ Res 49:1069-1081, 1981
26. Priori SG, Yamada KA, Corr PB: Influence of hypoxia on adrenergic modulation of triggered activity in isolated adult canine myocytes. Circulation 83:248-259, 1991
27. Janse MJ, van Capelle FJ, Morsink H, et al: Flow of "injury" current and patterns of excitation during early ischemia in isolated porcine and canine hearts: Evidence for two different arrhythmogenic mechanisms. Circ Res 47:151-165, 1980
28. Katzung B: Electrically induced automaticity in ventricular myocardium. Life Sci 14:1133-1140, 1974
29. Coraboeuf E, Deroubaix E, Coulombe A: Acidosis-induced abnormal repolarization and repetitive activity in isolated dog Purkinje fibers. J Physiol (Paris) 76:97-106, 1980
30. Pogwizd SM, Onufer JR, Kramer JB, et al: Induction of delayed afterdepolarizations and triggered activity in canine Purkinje fibers by lysophosphoglycerides. Circ Res 59:416-426, 1986
31. Karagueuzian HS, Pennec JP, Deroubaix E, et al: Effects of excess free acids on the electrophysiological properties of ventricular specialized conducting tissue: A comparative study between the sheep and the dog. J Cardiovasc Pharmacol 4:462-468, 1982
32. Janse MJ, Wit AL: Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 69:1049-1169, 1989
33. MacLeod BA, Augereau P, Walker MJA: Effects of halothane anesthesia compared with fentanyl anesthesia and no anesthesia during coronary ligation in rats. Anesthesiology 58:44-52, 1983
34. Kroll DA, Knight PR: Antifibrillatory effects of volatile anesthetics in acute occlusion/reperfusion arrhythmias. Anesthesiology 61:657-661, 1984
35. + conductance of myocardium. J Pharmacol Exp Ther 265:358-365, 1993
36. Puddu PE, Jouve R, Langlet F, et al: Prevention of postischemic ventricular fibrillation late after right or left stellate ganglionectomy in dogs. Circulation 77:935-946, 1988
37. Corr PB, Yamada KA, Witkowsky FX: Mechanisms controlling cardiac autonomic function and their relation to arrhythmogenesis, in Fozzard HA, Haber E, Jennings RB, et al (eds): The Heart and Cardiovascular System. New York, NY, Raven Press, 1986, pp 1343-1403
38. Corr PB, Yamada KA, DaTorre SD: Modulation of α-adrenergic receptors and their intracellular coupling in the ischemic heart. Basic Res Cardiol 85:31-45, 1990 (suppl 1)
39. Hayashi Y; Sumikawa K, Tashiro C, Yoshiya I: Synergistic interaction of α1- and β-adrenoceptor agonists on induction arrhythmias during halothane anesthesia in dogs. Anesthesiology 68:902-907, 1988
40. Seagard JL, Bosnjak ZJ, Hopp FAJ, et al: Cardiovascular effects of general anesthesia, in Covino BG, Fozzard HA, Rehder K, et al: Effects of Anesthesia. Bethesda, MD, American Physiological Society, 1985, pp 149-177
41. Bekheit S, Isber N, Jani H, et al: Reduction of ischemia-induced electrophysiologic abnormalities by glucose-insulin infusion. J Am Col Cardiol 22:1214-1222, 1993
42. Cardinal R, Janse MJ, Van Eeden I, et al: The effects of lidocaine on extracellular and intracellular potentials, activation and arrhythmias during acute regional ischemia in the isolated porcine heart. Circ Res 49:792-801, 1980
43. Uprichard AGC, Lucchesi BR: Antifibrillatory drugs, in Dangman KH, Miura DS (eds): Electrophysiology and Pharmacology of the Heart: A Clinical Guide. New York, NY, Marcel Dekker, 1991, pp 723-740
44. Emergency Cardiac Care Committee and Subcommittees American Heart Association: Guidelines for cardiopulmonary resuscitation and emergency cardiac care. JAMA 268:2171-2302, 1992
45. Levine JH, Massumi A, Scheinman MM, et al: Intravenous amibdarone for recurrent sustained hypotensive ventricular tachyarrhythmias. J Am Coll Cardiol 27:67-75, 1996
46. Kowey PR, Levine JH, Herre JM, et al: Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. Circulation 92:3255-3263, 1995
47. Scheinman MM, Levine JH, Cannom DS, et al: Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation 92:3264-3272, 1995
48. Teo KK, Yusuf S, Furberg CD: Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: An overview of results from randomized controlled trials. JAMA 270:1589-1595, 1993
49. MacMahon S, Collins R, Peto R, et al: Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized, controlled trials. JAMA 260:1910-1916, 1988
50. Yusuf S, Flather M: Magnesium in acute myocardial infarction. ISIS 4 provides no grounds for its routine use. Br Med J 310:751-752, 1995
51. ISIS-4 Collaborative Group: ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58 050 patients with suspected acute myocardial infarction. Lancet 345:669-685, 1995
52. Mehra R, Zeiler RH, Gough WB, El-Sherif N: Reentrant ventricular arrhythmias in the late myocardial infarction period. 9. Electrophysiologic-anatomic correlation of reentrant circuits. Circulation 67:11-24, 1983
53. Friedman PL, Stewart JR, Fenoglio JJJ, Wit AL: Survival of subendocardial Purkinje fibers after extensive myocardial infarction: In vitro and in vivo correlations. Circ Res 33:612-626, 1973
54. Michelson EL, Spear JF, Moore EN: Electrophysiologic and anatomic correlates of sustained ventricular tachyarrhythmias in a model of chronic myocardial infarction. Am J Cardiol 45:583-590, 1980
55. de Bakker JMT, van Capelle FJL, Janse MJ, et al: Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: Electrophysiologic and anatomic correlation. Circulation 77:589-606, 1988
56. Tennant R, Wiggers CJ: The effect of coronary occlusion on myocardial contraction. Am J Physiol 112:351-361, 1935
57. Balke CW, Kaplinsky EL, Michelson EL, et al: Reperfusion ventricular tachyarrhythmias: Correlation with antecedent coronary artery occlusion tachyarrhythmias and duration of myocardial ischemia. Am Heart J 101:449-456, 1981
58. Jennings RB, Sommers HM, Smyth GA, et al: Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol 70:68-78, 1960
59. Austin M, Wenger TL, Harrell FEJ, et al: Effect of myocardium at risk on outcome after coronary artery occlusion and release. Am J Physiol 243:H340-H349, 1982
60. Lederman SN, Wenger TL, Harrell FE, Strauss HC: Effects of different paced heart rates on canine coronary occlusion and reperfusion arrhythmias. Am Heart J 113:1365-1369, 1987
61. Pogwizd SM, Corr PB: Electrophysiological mechanisms underlying arrhythmias due to reperfusion of ischemic myocardium. Circulation 76:404-426, 1987
62. Ferner GR, Moffat MP, Lukas A: Possible mechanisms of ventricular arrhythmias elicited by ischemia followed by reperfusion: Studies on isolated canine ventricular tissues. Circ Res 56:184-194, 1985
63. Goldhaber JI, Weiss JN: Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension 20:118-127, 1992
64. Barrington PL, Meier CFJ, Weglicki WB: Abnormal electrical activity induced by free radical generating systems in isolated cardiocytes. J Mol Cell Cardiol 20:1163-1178, 1988
65. Matsuura H, Shattuck MJ: Membrane potential fluctuations and transient inward currents induced by reactive oxygen intermediates in isolated rabbit ventricular cells. Circ Res 68:319-329, 1991
66. Ono K, Fozzard HA: Phosphorylation restores activity of L-type calcium channels after rundown in inside-out patches from rabbit cardiac cells. J Physiol (Lond) 454:673-688, 1992
67. Buljubasic N, Marijic J, Stowe DF, et al: Halothane reduces dysrhythmias and improves contractile function after global hypoperfusion in isolated hearts. Anesth Analg 74:384-394, 1992
68. Krumholz HM, Goldberger AL: Reperfusion arrhythmias after thrombolysis: Electrophysiologic tempest, or much ado about nothing. Chest 99:1358-1405, 1991
69. Gressin V, Louvard Y, Pezzano M, Lardoux H: Holter recording of ventricular arrhythmias during intravenous throrabolysis for acute myocardial infarction. Am J Cardiol 69:152-159, 1992
70. Hohnloser SH, Zabel M, Olschewski M, et al: Arrhythmias during the acute phase of reperfusion therapy for acute myocardial infarction: Effects of beta-adrenergic blockade. Am Heart J 123:1530-1535, 1992
71. Karagueuzian HS, Liu ZW, Yao F, et al: Suppression of reperfusion ventricular fibrillation by metoprolol-quinidine combination. Rev Biomed Int 12:69, 1990 (abstr)
72. Naito M, Michelson EL, Kmetzo JJ, et al: Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation. Circulation 63:70-79, 1981
73. Rosenfeld J, Rosen MR, Hoffman BF: Pharmacologic and behavioral effects on arrhythmias that immediately follow abrupt coronary occlusion: A canine model of sudden coronary death. Am J Cardiol 41:1075-1082, 1978
74. Wenger XL, Lederman S, Starmer FC, et al: A method for quantitating anti-fibrillatory effects of drugs after coronary reperfusion in dogs: Improved outcome with bretylium. Circulation 69:142-148, 1984
75. El-Sherif N, Gough WB, Zeiler RH, Mehra R: Triggered ventricular rhythm in one-day-old myocardial infarction in the dog. Circ Res 52:566-579, 1983
76. El Sherif N, Mehra R, Gough WB, et al: Ventricular activation patterns of spontaneous and induced ventricular rhythms in canine one-day-old myocardial infarction: Evidence for focal ands reentrant mechanisms. Circ Res 51:152-166, 1982
77. Dangman KH, Dresdner DP, Zaim S: Automatic and triggered impulse initiation in canine subepicardial ventricular muscle cells from border zones of 24-hour transmural infarcts: New mechanisms for malignant cardiac arrhythmias? Circulation 78:1020-1030, 1988
78. Turner LA, Bosnjak ZJ, Kampine JP: Actions of halothane on the electrical activity of Purkinje fibers derived from normal and infarcted canine hearts. Anesthesiology 67:619-629, 1987
79. Dresdner KP, Kline RP, Wit AL: Intracellular K+ activity, intracellular Na+ activity and maximum diastolic potential of canine subendocardial Purkinje cells from one-day-old infarcts. Circ Res 60:122-132, 1987
80. Dresdner KP, Kline RP, Wit AL: Intracellular pH of canine subendocardial Purkinje cells surviving in 1-day-old myocardial infarcts. Circ Res 65:554-565, 1989
81. Argentieri TM, Frame LH, Colatsky TJ: Electrical properties of canine subendocardial Purkinje fibers surviving in 1-day-old experimental myocardial infarction. Circ Res 66:123-134, 1990
82. Bigger JTJ, Dresdale RJ, Heissenbuttel RH, et al: Ventricular arrhythmias in ischemic heart disease: Mechanism, prevalence, significance, and management. Prog Cardiovasc Dis 19:255-300, 1977
83. Nattel S, Pederson DH, Zipes DP: Alterations in regional myocardial distribution and arrhythmogenic effects of aprinidine produced by coronary artery occlusion in the dog. Cardiovasc Res 15:80-85, 1981
84. Davis J, Glassman R, Wit AL: Method for evaluating the effects of antiarrhythmic drugs on ventricular tachycardia with different electrophysiological characteristics and different mechanisms in the infarcted canine heart. Am J Cardiol 49:1176-1184, 1982
85. Logic JR, Morrow DH, Gatz RN: Idioventricular tachycardia complicating experimental myocardial infarction. Dis Chest 56:477-480, 1969
86. Gallagher JD, McClernan CA: The effects of halothane on ventricular tachycardia in intact dogs. Anesthesiology 75:866-875, 1991
87. Laszlo A, Polic S, Kampine JP, et al: Halothane, enflurane and isoflurane on abnormal automaticity and triggered rhythmic activity of Purkinje fibers from 24-hour-old infarcted canine hearts. Anesthesiology 75:847-853, 1991
88. Komai H, Rusy BF: Halothane directly inhibits sarcoplasmic reticular function in intact myocardium. Anesthesiology 67:A54, 1987 (abstr)
89. Komai H, Rusy BF: Direct effect of halothane and isoflurane on the function of the sarcoplasmic reticulum in intact rabbit atria. Anesthesiology 72:694-698, 1990
90. Eger EI II: Anesthetic Uptake and Action. Baltimore, MD, Williams & Wilkins, 1974
91. Gallagher JD: Effects of isoflurane on ouabain toxicity in canine Purkinje fibers: Comparison with halothane. Anesthesiology 81:1500-1510, 1994
92. Norris RM, Mercer CJ: Significance of idioventricular rhythms in acute myocardial infarction. Prog Cardiovasc Dis 16:455-468, 1974
93. Sclarovsky S, Strasberg B, Fuchs J, et al: Multiform accelerated idioventricular rhythm in acute myocardial infarction: Electrocardiographic characteristics and response to verapamil. Am J Cardiol 52:43-47, 1983
94. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology: The "Sicilian Gambit": A new approach to the classification of antiarrhythmic drugs based on their actions on antiarrhythmic mechanisms. Eur Heart J 12:1112-1131, 1991
95. Josephson ME, Horowitz LH, Farshidi A, Kastor JA: Recurrent sustained ventricular tachycardia in man. 1. Mechanisms. Circulation 57:431-440, 1978
96. Josephson ME, Wit AL: Fractionated electrical activity and continuous electrical activity: Fact or artifact? Circulation 70:529-532, 1984
97. Garan H, Ruskin JN, McGovern B, Grant G: Serial analysis of electrically induced ventricular arrhythmias in a canine model of myocardial infarction. J Am Coll Cardiol 5:1095-1106, 1985
98. Karagueuzian HS, Fenoglio JJJ, Weiss MB, Wit AL: Protracted ventricular tachycardia induced by premature stimulation of the canine heart after coronary artery occlusion and reperfusion. Cire Res 44:833-846, 1979
99. Hanish RF, DeLangen CDJ, Kadish AH, et al: Inducible sustained ventricular tachycardia 4 years after experimental canine myocardial infarction: Electrophysiologic and anatomic comparison with early healed infarcts. Circulation 77:445-456, 1988
100. Spear JF, Michelson EL, Moore EN: Reduced space constant in slowly conducting regions of chronically infarcted canine myocardium. Circ Res 53:176-185, 1983
101. Gessman LJ, Agarwal JB, Endo T, Helfant RH: Localization and mechanism of ventricular tachycardia by ice mapping 1 week after onset of myocardial infarction in dogs. Circulation 68:657-666, 1983
102. Spear JF, Horowitz LN, Hodess AB, et al: Cellular electrophysiology of human myocardial infarction. I. Abnormalities of cellular activation. Circulation 59:247-256, 1979
103. El-Sherif N, Smith RA, Evans K: Canine ventricular arrhythmias in the late myocardial infarction period. 8. Epicardial mapping of reentrant circuits. Circ Res 49:255-265, 1981
104. Restivo M, Gough WB, El-Sherif N: Reentrant ventricular rhythms in the late myocardial infarction period: Prevention of reentry by dual stimulation during basic rhythm. Circulation 77:429-444, 1988
105. Dillon SM, Allessie MA, Ursell PC, Wit AL: Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circ Res 63:182-206, 1988
106. Pogwizd SM, Hoyt RH, Saffitz JE, et al: Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation 86:1872-1887, 1992
107. Deutsch N, Hantler CB, Tait AR: QT interval lengthening with halothane, enflurane, and isoflurane in dogs with recent myocardial infarction. Eleventh Annual Meeting of the Society of Cardiovascular Anesthesiologists, Seattle, WA, 1989 (abstr)
108. Hunt GB, Ross DL: Comparison of effects of three anesthetic agents on induction of ventricular tachycardia in a canine model of myocardial infarction. Circulation 78:221-226, 1988
109. Denniss AR, Richards DA, Taylor AT, Uther JB: Halothane anesthesia reduces inducibility of ventricular tachyarrhythmias in chronic canine myocardial infarction. Basic Res Cardiol 84:5-12, 1989
110. Deutsch N, Hantler CB, Tait AR, et al: Suppression of ventricular arrhythmias by volatile anesthetics in a canine model of chronic myocardial infarction. Anesthesiology 72:1012-1021, 1990
111. Levine JH, Morganroth J, Kadish AH: Mechanisms and risk factors for proarrhythmia with type 1a compared with 1c antiarrhythmic drug therapy. Circulation 80:1063-1069, 1989
112. Velebit V, Podrid P, Lown B, et al: Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 65:886-894, 1982
113. Turner LA, Polic S, Hoffmann RG, et al: Actions of halothane and isoflurane on Purkinje fibers in the infarcted canine heart: Conduction, regional refractoriness and reentry. Anesth Analg 76:718-725, 1993
114. Zipes DP, Prystowsky EN, Heger JJ: Amiodarone: Electrophysiologic actions, pharmacokinetics and clinical effects. J Am Coll Cardiol 3:1059-1071, 1984
115. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406-412, 1989
116. Horowitz LN, Harken AH, Kastor JA, Josephson ME: Ventricular resection guided by epicardial and endocardial mapping for treatment of recurrent ventricular tachycardia. N Engl J Med 302:589-593, 1980
117. Saksena S, Tullo NG, Krol RB, Mauro AM: Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system. Arch Intern Med 149:2333-2339, 1989
118. Waldo AL, Biblo LA, Carlson MD: Ventricular arrhythmias in perspective: A current view. Am Heart J 123:1140-1147, 1992
119. Singh BN: Choice and chance in drug therapy of cardiac arrhythmias: Technique versus drug-specific responses in the evaluation of therapy. Am J Cardiol 72:114F-124F, 1993
120. Colatsky TJ, Follmer CH, Starmer CF: Channel specificity in antiarrhythmic drug action: Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 82:2235-2242, 1990
121. Tzivoni D, Banai S, Schuger C, et al: Treatment of torsade de pointes with magnesium sulfate. Circulation 77:392-397, 1988
122. Allen BJ, Brodsky MA, Capparelli EV, et al: Magnesium sulfate therapy for sustained monomorphic ventricular tachycardia. Am J Cardiol 64:1202-1204, 1989
123. O'Kelly B, Browner WS, Massie B, et al: Ventricular arrhythmias in patients undergoing noncardiac surgery. JAMA 268:217-221, 1992
124. Mirowski M, Mower MM, Reid PR, et al: The automatic implantable defibrillator: New modality for treatment of life-threatening ventricular arrhythmias. PACE Pacing Clin Electrophysiol 5:384-401, 1982
125. Rinkenberger RL, Prystowsky EN, Jackman WM, et al: Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: Identification of drugs that exacerbate tachycardia and potential mechanisms. Am Heart 1103:177-184, 1982
126. Slater W, Lampert S, Podrid PJ, Lown B: Clinical predictors of arrhythmias worsening by antiarrhythmic drugs. Am J Cardiol 61:349-353, 1988
127. Wilbur DJ, Davis MJ, Rosenbaum M, et al: Incidence and determinants of multiple morphologically distinct sustained ventricular tachycardias. Am Coll Cardiol 10:583-591, 1987
128. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology: CAST and beyond: Implications of the Cardiac Arrhythmia Suppression Trial. Circulation 81:1123-1127, 1990
129. Lischke V, Behne M, Doelken P, et al: Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg 79:983-986, 1994
130. Martyn R, Somberg JC, Kerin NZ: Proarrhythmia of nonantiarrhythmic drugs. Am Heart J 126:201-205, 1993
131. Keating MT: The long QT syndrome: A review of recent molecular genetic and physiologic discoveries. Medicine 75:1-5, 1996
132. Hondeghem LM, Snyders DJ: Class III antiarrhythmic agents have a lot of potential but a long way to go: Reduced effectiveness and dangers of reverse use dependence. Circulation 81:686-690, 1990
133. Balser JR, Bennett PB, Hondeghern LM, Roden DM: Suppression of time-dependent outward current in guinea pig ventricular myocytes: Actions of quinidine and amiodarone. Circ Res 69:519-529, 1991
134. + current: Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96:195-215, 1990
135. Singh BN: Controlling cardiac arrhythmias by lengthening repolarization: Historical overview. Am J Cardiol 72:18F-24F, 1993
136. Morganroth J: Proarrhythmic effects of antiarrhythmic drugs: Evolving concepts. Am Heart J 123:1137-1139, 1992
137. Mason JW, Stinson EB, Winkle RA, Oyer PE: Mechanisms of ventricular tachycardia: Wide complex ignorance. Am Heart J 102:1083-1087, 1981
138. Kerin NZ, Somberg J: Proarrhythmia: Definition, risk factors, causes, treatment, and controversies. Am Heart J 128:575-585, 1994
139. Hoffman B: Mechanisms of antiarrhythmic actions, in Zipes DP, Jalife J (eds): Cardiac Electrophysiology and Arrhythmias. Orlando, FL, Grune & Stratton, 1985, pp 193-197